Target intelligence / Profile preview

Phosphodiesterase with HD-GYP domain (HD-GYP phosphodiesterase)

Target
HD-GYP phosphodiesterase
Molecular classification
Enzyme, Phosphodiesterase, HD domain superfamily
01

Overview

Phosphodiesterases with HD-GYP domains are bacterial enzymes belonging to the HD domain superfamily, uniquely equipped to hydrolyze cyclic di-GMP (bis-(3',5')-cyclic dimeric guanosine monophosphate)—a key bacterial second messenger controlling cellular processes such as biofilm formation, motility, and virulence[1][3][4]. HD-GYP phosphodiesterases contain conserved motifs (HD and GYP) that coordinate transition metal ions (commonly Fe) in their active site, essential for catalysis[4][6]. They frequently act in opposition to diguanylate cyclases (GGDEF domain proteins) to fine-tune cyclic dinucleotide levels[1]. By modulating signal transduction pathways, these enzymes critically affect bacterial adaptation and pathogenicity, making them candidate targets for anti-biofilm and antimicrobial drug design[2]. No clinically approved drugs yet target these enzymes, but mechanistic knowledge underpins current efforts in therapeutic inhibitor development[2].

Other names
HD-GYP proteinHD-GYP domain phosphodiesterasec-di-GMP phosphodiesterase (HD-GYP type)
02

Mechanism of action

Hydrolysis of cyclic di-GMP or related cyclic dinucleotides, converting them into linear di-nucleotides or mononucleotides Modulation of bacterial secondary messenger levels, thereby altering bacterial physiology and pathogenicity[1][4].

03

Biological functions

Signal transductionRegulation of biofilm formationControl of motilityRegulation of virulence in bacteria
04

Disease associations

Infection (bacterial pathogenesis, biofilm-related disease)Other (modulation of microbial virulence/resistance)
05

Safety considerations

Human toxicity not directly relevant due to bacterial specificity; potential concern for off-target microbiome effects if pharmacologically targeted.
06

Biomarkers

Changes in c-di-GMP levels serve as biomarkers for biofilm formation, virulence, and motility states in bacteria.

Beyond the preview

Go deeper on Phosphodiesterase with HD-GYP domain (HD-GYP phosphodiesterase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphodiesterase with HD-GYP domain (HD-GYP phosphodiesterase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call